Contract manufacturing service for liquid media for biotechnology product development.
Domestic manufacturing and stable procurement | Contract manufacturing of liquid media in compliance with GMP
In the biotechnology industry, a stable supply of liquid culture media optimal for cell culture is essential for product development. Particularly in the field of regenerative medicine, such as iPS cells and mesenchymal stem cells, the quality of the media affects the performance of the products. A GMP-compliant manufacturing environment and strict quality control are required. Our company offers contract manufacturing services for GMP-compliant liquid media to support your product development. 【Usage Scenarios】 - Cell culture in the field of regenerative medicine, such as iPS cells and mesenchymal stem cells - Development of biopharmaceuticals - Smooth transition from research media to clinical media 【Benefits of Implementation】 - Stable supply of high-quality media compliant with GMP - Aseptic filling into containers tailored to customer requirements - Reduction of research and development time and cost savings
basic information
【Features】 - Manufacturing environment compliant with GMP - Production line capable of handling small quantities and a variety of products - Extensive use of single-use equipment - Strict raw material management - Smooth transition from research use to clinical use 【Our Strengths】 As a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Ltd., we contribute to the field of regenerative medicine by combining high-quality amino acid-based culture media raw materials with advanced production technology. With a GMP-compliant manufacturing system and extensive track record, we strongly support our customers' product development.
Price information
Please contact us separately.
Delivery Time
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog（3）
Download All Catalogs
Recommended products
Distributors
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.